Difference between revisions of "Plasminogen activator inhibitor-2"
| Line 36: | Line 36: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 08:44, 25 July 2007
| Template:Infobox header| Plasminogen activator inhibitor-2 | |
|---|---|
| Plasminogen activator inhibitor-2 | |
| Substrate peptide name | Plasminogen activator inhibitor-2 |
| Synonyms | Urokinase inhibitor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol
Plasma |
| Swissprot ID | P05120 |
| Reactive glutamines | Q83, Q84, Q86 |
| Reactive lysines | Not determined yet |
| Substrate sequence | SCGFMQQIQKGSYP |
| Structure | 1BY7 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:7910824 |
| Notes | Polymerization occurs upon transglutaminase action
Crosslinking by TG2 has no effect on the protein's function/activity. |
| Template:Infobox header | | |
